STAAR Surgical | STAA - Cash And Equivalent

Stock Price
32.07
Daily Change
0.06 0.19%
Monthly
30.26%
Yearly
66.86%
Q2 Forecast
31.43

STAAR Surgical reported $153.15M in Cash and Equivalent for its fiscal quarter ending in December of 2025.





Cash And Equivalent Change Date
Abbott USD 6.8B 1.72B Mar/2026
Bausch Health Companies USD 1.31B 1000K Dec/2025
Boston Scientific USD 1.45B 512M Mar/2026
Cerus USD 19.96M 4.29M Dec/2025
Cooper Companies USD 110.6M 14.3M Sep/2025
J&J USD 21.69B 1.98B Mar/2026
Merit Medical Systems USD 488.08M 41.68M Mar/2026
Novartis USD 6.88B 4.56B Mar/2026
OraSure Technologies USD 176.96M 22.31M Mar/2026
Orthofix International USD 120.28M 38.25M Mar/2026
Rockwell Medical USD 12.48M 1.09M Jun/2025
STAAR Surgical USD 153.15M 23M Dec/2025
Utah Medical Products USD 84.27M 2.09M Sep/2025